Cargando…
RAD51-Mediated DNA Homologous Recombination Is Independent of PTEN Mutational Status
SIMPLE SUMMARY: PTEN is an important tumor suppressor that is frequently mutated in malignancy. PTEN mutational loss has been associated with reduced RAD51 expression and homologous recombination deficiency (HRD), however; recent studies have failed to recapitulate these findings. Here, we show that...
Autores principales: | Sinha, Asha, Saleh, Ali, Endersby, Raelene, Yuan, Shek H., Chokshi, Chirayu R., Brown, Kevin R., Kuzio, Bozena, Kauppinen, Tiina, Singh, Sheila K., Baker, Suzanne J., McKinnon, Peter J., Katyal, Sachin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693555/ https://www.ncbi.nlm.nih.gov/pubmed/33138032 http://dx.doi.org/10.3390/cancers12113178 |
Ejemplares similares
-
Homologous Pairing Activities of Two Rice RAD51 Proteins, RAD51A1 and RAD51A2
por: Morozumi, Yuichi, et al.
Publicado: (2013) -
Rad51 Paralogs Remodel Pre-synaptic Rad51 Filaments to Stimulate Homologous Recombination
por: Taylor, Martin R.G., et al.
Publicado: (2015) -
Homologous recombination, cancer and the ‘RAD51 paradox’
por: Matos-Rodrigues, Gabriel, et al.
Publicado: (2021) -
DNA-PK hyperactivation occurs in deletion 11q chronic lymphocytic leukemia and is both a biomarker and therapeutic target for drug-resistant disease
por: Kost, Sara E. F., et al.
Publicado: (2023) -
PTEN Loss Enhances Error-Prone DSB Processing and Tumor Cell Radiosensitivity by Suppressing RAD51 Expression and Homologous Recombination
por: Pei, Xile, et al.
Publicado: (2022)